Oncoscope Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 11
Employees
  • Latest Deal Type
  • M&A

Oncoscope General Information

Description

Developer of clinical optical imaging applications. The company develops optical imaging systems which provides images and information on tissue microstructure for the purpose of epithelial tissues in the oral cavity, esophagous, stomach, colon, lung, cervix and bladder.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 318 Blackwell Street
  • Suite 240
  • Durham, NC 27701
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoscope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 23-Feb-2016 00.000 Completed Generating Revenue
6. Later Stage VC 21-Jan-2014 00.000 Completed Generating Revenue
5. Debt - General 11-Oct-2012 00000 00.000 Completed Generating Revenue
4. Later Stage VC (Series A2) 23-Sep-2011 000 00.000 00.00 Completed Startup
3. Early Stage VC (Series A1) 26-May-2010 00.00 00.000 00.00 Completed Startup
2. Early Stage VC (Series A) 15-Dec-2008 $2.09M $2.09M 00.000 Completed Startup
1. Grant $4.6M Completed Startup
To view Oncoscope’s complete valuation and funding history, request access »

Oncoscope Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 2,608,259 $0.001000 $0.8 $0.8 1x $0.8 9.23%
To view Oncoscope’s complete cap table history, request access »

Oncoscope Executive Team (2)

Name Title Board Seat Contact Info
Perry Genova Ph.D President, Board Member & Chief Executive Officer
Michael Tolliver Chief Financial Officer
To view Oncoscope’s complete executive team members history, request access »

Oncoscope Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoscope Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Applied Ventures Corporate Venture Capital Minority 000 0000 000000 0
Arcus Ventures Venture Capital Minority 000 0000 000000 0
Fulcrum Financial Partners Venture Capital Minority 000 0000 000000 0
IDEA Fund Partners Venture Capital Minority 000 0000 000000 0
NC Idea Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »